FREEtelehealth consult with Medicare (bulk-billed)
A Specialist GP talks you through prostate cancer screening over a quick phone call. They explain what the PSA blood test involves, weigh up the pros and cons for your age and family history, and arrange your pathology referral by SMS if you decide to go ahead.
Book a telehealth consult — free with Medicare (bulk-billed)
Talk through the pros, cons and your personal risk with a Specialist GP
PSA test referred by SMS if you choose — your result reviewed and explained
Prostate cancer screening means checking for early signs of prostate cancer in men who feel well and have no symptoms, with the aim of finding any cancer early — when it’s most treatable. In Australia, the main test used for screening is a simple blood test called the PSA test. Unlike bowel or breast cancer, there isn’t a national invitation-based prostate screening program; instead, PSA testing is offered and discussed between a man and his doctor.
Prostate cancer is one of the most commonly diagnosed cancers in Australian men, and while many prostate cancers grow slowly, some are aggressive and can spread if not caught in time. Early prostate cancer usually causes no symptoms at all — by the time symptoms appear, a cancer may be more advanced. The goal of screening is to catch the cancers that could cause harm while they’re still curable, without causing unnecessary worry or treatment for the many prostate changes that would never have caused a problem. Getting that balance right is what modern screening is all about — which is why an informed, considered approach matters more than a simple yes or no.
The PSA Test Explained
PSA stands for prostate-specific antigen, a protein made by the prostate that circulates in the blood. The PSA test is a straightforward blood test that measures how much of it is present. The prostate naturally grows and produces more PSA from around the age of 40, so PSA levels are interpreted according to your age — what’s normal for a 45-year-old differs from what’s normal at 65.
A higher-than-expected PSA for your age suggests something is going on with the prostate that’s worth looking into — but importantly, that “something” is often not cancer. PSA can be raised by a benign (non-cancerous) enlarged prostate, inflammation or infection, recent vigorous exercise or ejaculation, and other harmless causes. So the PSA test is a useful first step, not a diagnosis on its own.
Australia’s Updated 2025 Guidance
Australia’s approach to PSA testing was substantially updated in 2025, replacing older guidance from 2016. The new guidelines reflect advances in MRI imaging, biopsy techniques and treatment, and mark a shift from waiting for men to raise the topic towards a more proactive, risk-based approach. The headline changes are:
Doctors are encouraged to start the conversation about PSA testing, rather than leaving it to the patient to ask.
Two-yearly PSA testing is offered to men aged 50–69 as a matter of course.
A baseline PSA test can be offered from age 40 for men interested in their prostate health, to help gauge risk.
The finger (digital rectal) exam is no longer routinely recommended as a screening test in general practice.
An MRI scan is now used before any biopsy, which reduces unnecessary biopsies.
Low-risk cancers are increasingly monitored (active surveillance) rather than treated straight away, to avoid overtreatment.
Together these changes aim to find the cancers that matter earlier, while sparing men from unnecessary tests and treatments — a more systematic and safer approach than before.
When to start and how often
Under the updated guidance, a reasonable approach for men at average risk is:
Age
Suggested approach
40
Consider a baseline PSA test if you’re interested in your prostate health — this helps understand your future risk.
50–69
PSA testing every 2 years is offered, after a conversation about the pros and cons.
70+
An individual decision based on your overall health and life expectancy, rather than routine testing.
Men at higher risk (see below) are generally advised to start earlier and test more often — often every two years from age 40. Your doctor will help you work out the right schedule for your situation.
Who Is at Higher Risk of Prostate Cancer
Some men have a higher-than-average risk and benefit from starting screening earlier. Higher risk includes:
Family history — a father or brother diagnosed with prostate cancer, or two more distant relatives, raises your risk.
Certain inherited gene changes — such as a BRCA2 mutation, and some hereditary cancer syndromes.
Ancestry — men of sub-Saharan African ancestry have a higher risk.
Aboriginal and Torres Strait Islander men — for whom PSA testing every two years from age 40 is recommended.
If any of these apply to you, it’s worth raising prostate screening with your doctor earlier — from around age 40 — rather than waiting until 50.
The Benefits — and the Downsides
The main benefit of prostate cancer screening is straightforward and important: it can find prostate cancer early, before symptoms, when it’s most treatable and most likely to be cured. Catching an aggressive cancer while it’s still confined to the prostate can be lifesaving, and early detection also opens up a fuller range of treatment options. For men at higher risk in particular, screening offers real reassurance and the chance to act early. The modern MRI-first pathway also means fewer men need invasive tests to sort out a raised PSA.
The downsides and limitations
PSA screening isn’t perfect, and being aware of its limitations is part of making an informed choice:
False alarms: a raised PSA often turns out not to be cancer, but can lead to worry and further tests before that’s clear.
Finding harmless cancers (overdiagnosis): screening can detect slow-growing cancers that would never have caused harm in a man’s lifetime.
Overtreatment: historically, some of those harmless cancers were treated unnecessarily, and treatment can have side effects such as urinary and erectile problems.
A normal PSA isn’t a guarantee: occasionally cancer is present despite a normal result.
The good news is that the updated approach — MRI before biopsy, and active surveillance for low-risk cancers — is specifically designed to reduce these harms, so the balance of benefit to harm is better than it used to be.
What Happens if Your PSA Is High
A single raised PSA result doesn’t mean you have cancer, and it doesn’t lead straight to a biopsy. Usually the test is simply repeated after a short interval to confirm the result, since PSA can fluctuate. If it remains elevated, the next step is generally an MRI scan of the prostate, which helps show whether there’s an area of concern and how likely it is to be significant. Only if the MRI and PSA suggest it’s warranted is a biopsy considered — and even then, if a cancer is found and it’s low-risk, careful monitoring (active surveillance) may be recommended rather than immediate treatment. This step-by-step pathway is designed to avoid unnecessary procedures.
Screening versus symptoms
Screening is for men without symptoms. If you do have symptoms — such as trouble passing urine, a weak or interrupted stream, needing to go more often (especially at night), blood in the urine or semen, or pelvic or back pain — these aren’t screening situations and should be assessed by a doctor regardless of your screening plans. It’s worth knowing that these symptoms are far more often caused by a benign enlarged prostate than by cancer, but they still deserve a check to find the cause and provide relief.
Making an Informed Choice
Because prostate cancer screening has both clear benefits and real trade-offs, it’s considered a personal, informed decision rather than something everyone must do. A good conversation with your doctor covers your age, family history and risk, how you feel about the possibility of false alarms or finding a harmless cancer, and what testing would mean for you. There’s no single right answer for everyone — the right choice is the one that fits your risk and your values, made with clear information. What matters most is that the decision is yours, and an informed one.
How screening works with Clinic365
A Specialist GP reviews your age, symptoms and family history over a quick phone call, explains the pros and cons in plain language, and — if you decide to test — sends a pathology referral by SMS. You attend any pathology lab Australia-wide, simply walking in, and your GP reviews and explains your result. If it needs following up, they guide you through the next steps along the MRI-first pathway. Consider booking a chat if you’re aged 50 to 69 (or from 40 if you have higher-risk factors or want a baseline), or if prostate cancer runs in your family — and see a doctor promptly, separate from screening, if you have urinary symptoms, blood in the urine or semen, or unexplained pelvic or bone pain.
Frequently asked questions
It means checking for early signs of prostate cancer in men who feel well and have no symptoms, to find any cancer early when it’s most treatable. In Australia it’s done mainly with a simple blood test — the PSA test — offered and discussed between a man and his doctor. There’s no national invitation program as there is for bowel or breast cancer; instead it’s an individual, informed decision.
PSA stands for prostate-specific antigen, a protein made by the prostate that circulates in the blood. The PSA test is a simple blood test measuring how much is present, interpreted according to your age since the prostate makes more PSA as you get older. A higher-than-expected level suggests something worth investigating — but often that’s not cancer, as benign enlargement, inflammation and other causes can raise PSA too.
Under Australia’s updated 2025 guidance, men at average risk are offered PSA testing every two years between ages 50 and 69, and can consider a baseline test from age 40 if interested in their prostate health. Men at higher risk — such as with a family history — are generally advised to start earlier, often from around 40. From age 70, it becomes an individual decision based on overall health.
For men at average risk aged 50 to 69, every two years is the suggested interval under the updated guidance. Men at higher risk may be tested more often, frequently every two years from age 40. Your doctor will help set the right schedule based on your age, risk factors and previous results. It isn’t a test most men need every year unless they’re at higher risk.
Higher risk includes having a father or brother diagnosed with prostate cancer (or two more distant relatives), certain inherited gene changes such as a BRCA2 mutation, and men of sub-Saharan African ancestry. Aboriginal and Torres Strait Islander men are advised to have PSA testing every two years from age 40. If any of these apply, it’s worth discussing screening with your doctor earlier, from around 40.
The main benefit is finding prostate cancer early, before symptoms, when it’s most treatable and most likely to be cured. Catching an aggressive cancer while it’s still confined to the prostate can be lifesaving and opens up more treatment options. For higher-risk men especially, screening offers reassurance and the chance to act early, and the modern MRI-first pathway means fewer men need invasive tests to sort out a raised PSA.
A raised PSA often isn’t cancer but can cause worry and lead to further tests; screening can also detect slow-growing cancers that would never have caused harm (overdiagnosis), which historically led to unnecessary treatment with side effects like urinary and erectile problems. A normal PSA also isn’t a total guarantee. The updated approach — MRI before biopsy and active surveillance for low-risk cancers — is designed to reduce these harms.
Under Australia’s updated 2025 guidance, the finger (digital rectal) examination is no longer routinely recommended as a screening test in general practice — the PSA blood test, followed by MRI if needed, is the preferred pathway. A doctor may still examine the prostate in certain situations, such as when assessing symptoms, but it’s no longer a routine part of screening men who feel well.
A single raised result doesn’t mean cancer and doesn’t lead straight to a biopsy. Usually the test is repeated after a short interval to confirm it, since PSA fluctuates. If it stays up, the next step is generally an MRI scan of the prostate to show whether there’s an area of concern. Only if MRI and PSA warrant it is a biopsy considered, and low-risk cancers may be monitored rather than treated immediately.
No. A high PSA means something is worth investigating, but it’s often not cancer. PSA can be raised by a benign enlarged prostate (common with age), inflammation or infection of the prostate, recent vigorous exercise or ejaculation, and other harmless causes. That’s why a raised result is followed by a repeat test and, if needed, an MRI, rather than assuming cancer or going straight to a biopsy.
It’s a personal, informed decision rather than something everyone must do. A good conversation with your doctor weighs your age, family history and risk, how you feel about false alarms or finding a harmless cancer, and what testing would mean for you. There’s no single right answer for everyone — the best choice fits your risk and your values, made with clear information. What matters is that the decision is yours and well-informed.
Early prostate cancer usually causes no symptoms, which is why screening exists. Possible symptoms of prostate problems include trouble passing urine, a weak or interrupted stream, needing to go more often (especially at night), and blood in the urine or semen, with pelvic or back pain in advanced disease. These are far more often due to a benign enlarged prostate than cancer, but should still be checked by a doctor.
